BioLife Solutions Interest Expense 2011-2026 | BLFS

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense BioLife Solutions

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
1.82 M	494 K	1.28 M	662 K	289 K	-	5 K	5 K	190 K	100 K	-	177 K	742 K	733 K	671 K	588 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.82 M	5 K	553 K

Quarterly Interest Expense BioLife Solutions

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
180 K	284 K	247 K	103 K	-	97 K	146 K	253 K	-	235 K	384 K	394 K	-	142 K	-22 K	131 K	-	-7 K	-	-	-	3 K	-	1 K	-	1 K	1 K	3 K	-	1 K	1 K	1 K	-	1.08 K	105 K	83.3 K	-	33.3 K	-	-	-	-	-	-	-	-	-	177 K	-	186 K	186 K	186 K	-	186 K	184 K	179 K	-	172 K	165 K	161 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
394 K	-22 K	127 K

Interest Expense of other stocks in the Medical instruments industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	149	-	-	$ 810 M	USA
The Cooper Companies COO	-16.4 M	$ 68.62	2.74 %	$ 13.7 B	USA
Glaukos Corporation GKOS	479 K	$ 126.34	3.59 %	$ 7.23 B	USA
Alcon ALC	204 M	$ 67.9	2.71 %	$ 40.4 B	Schweiz
ICU Medical ICUI	93.3 M	$ 142.0	3.29 %	$ 3.5 B	USA
iRhythm Technologies IRTC	5.44 M	$ 113.83	6.15 %	$ 3.64 B	USA
Repro Med Systems KRMD	9.91 K	$ 4.0	0.25 %	$ 185 M	USA
LeMaitre Vascular LMAT	5.18 M	$ 96.59	1.56 %	$ 2.19 B	USA
Masimo Corporation MASI	300 K	$ 179.95	0.01 %	$ 9.59 B	USA
Microbot Medical MBOT	-5 K	$ 1.82	-	$ 83.3 M	Israel
Ekso Bionics Holdings EKSO	-26 K	-	-	$ 28.6 M	USA
Milestone Scientific MLSS	60.3 K	$ 0.39	0.29 %	$ 32 M	USA
Merit Medical Systems MMSI	-2.39 M	$ 67.51	2.24 %	$ 3.99 B	USA
electroCore ECOR	14.9 K	$ 9.52	-1.24 %	$ 80.8 K	USA
Envista Holdings Corporation NVST	-2.3 M	$ 24.59	4.91 %	$ 4.13 B	USA
Haemonetics Corporation HAE	-28.7 M	$ 78.71	5.11 %	$ 3.71 B	USA
STERIS plc STE	9.8 M	$ 212.88	1.1 %	$ 20.9 B	USA
Isoray ISR	84 K	-	0.03 %	$ 108 M	USA
STAAR Surgical Company STAA	2.25 M	$ 29.87	-0.3 %	$ 1.48 B	USA
InfuSystem Holdings INFU	2 K	$ 9.01	-	$ 186 M	USA
Teleflex Incorporated TFX	85.1 M	$ 135.75	3.04 %	$ 6.06 B	USA
Utah Medical Products UTMD	-120 K	$ 68.07	1.52 %	$ 221 M	USA
West Pharmaceutical Services WST	-1 M	$ 334.66	4.66 %	$ 24.2 B	USA
Pulse Biosciences PLSE	-52 K	$ 25.77	3.74 %	$ 1.74 B	USA
DENTSPLY SIRONA XRAY	24 M	$ 10.47	2.05 %	$ 2.09 B	USA
Retractable Technologies RVP	152 K	$ 0.69	0.16 %	$ 20.7 M	USA
Pro-Dex PDEX	533 K	$ 65.0	-	$ 214 M	USA
Predictive Oncology POAI	3	-	-	$ 31.1 M	USA
Stereotaxis STXS	2 K	$ 1.85	2.21 %	$ 168 M	USA
Baxter International BAX	290 M	$ 20.03	4.16 %	$ 10.3 B	USA
ResMed RMD	3.2 M	$ 196.94	1.97 %	$ 28.8 B	USA
AtriCure ATRC	683 K	$ 27.3	1.43 %	$ 1.3 B	USA
Harvard Bioscience HBIO	-2.66 M	$ 6.04	0.5 %	$ 268 M	USA
AngioDynamics ANGO	4.94 M	$ 12.34	3.44 %	$ 504 M	USA
Becton, Dickinson and Company BDX	613 M	$ 152.04	2.08 %	$ 43.7 B	USA
Nephros NEPH	-78 K	$ 3.25	-4.13 %	$ 34.5 M	USA
OraSure Technologies OSUR	229 K	$ 4.24	2.17 %	$ 312 M	USA
Repligen Corporation RGEN	2.82 M	$ 130.13	3.83 %	$ 7.32 M	USA